" class="no-js "lang="en-US"> Neurodegenerative Archives - Medtech Alert
Friday, June 21, 2024

Sort by:

Date

Top Post

Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease

An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]

Eikonoklastes Announces Formation of Scientific Advisory Board

Eikonoklastes Therapeutics, a biopharmaceutical company developing a novel gene therapy platform to discover and develop […]

Therini Bio Raises $36M Series A Financing to Develop Fibrin-Targeted Therapies for Neurodegenerative and Retinal Diseases

Therini Bio, a biotech company aimed at developing fibrin-targeted therapies to treat inflammatory neurodegenerative and […]

Myrtelle Announces Positive 6-month Post-Treatment Data in Patients in Its First-in-Human Clinical Study of rAAV-Olig001-ASPA Gene Therapy in Canavan Disease

Myrtelle, a gene therapy company focused on developing transformative treatments for neurodegenerative diseases, has announced […]

José Baselga Research Fund Announces First-Ever Grant to Advance Prion Disease Research

The José Baselga Research Fund (JBRF), supported by Alexion, AstraZeneca Rare Disease, today announced the […]

Teitur Trophics Raises €28M in Series A Financing to Advance the Development and Treatment for Neurodegenerative Diseases

Teitur Trophics, a biotech company dedicated to developing new treatments for patients suffering from neurodegenerative […]

Pheno Therapeutics Announces Worldwide License from UCB to a Novel Program for Neurodegenerative Disease

Pheno Therapeutics, a biotechnology company focused on the discovery and development of small molecule therapeutics […]

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more